Association of Adenoid Hypertrophy with Nasal and Middle Ear Pathologies in Adults

A prospective comparative study was carried out in patients attending ENT Out Patient Department of a tertiary care Hospital with an aim to determine the association of adenoid hypertrophy with chronic nasal and middle ear pathologies in those aged 18 years or above. Patients presenting between August 2020 and February 2022 with chronic nasal and middle ear pathologies who underwent diagnostic nasal endoscopy were seen for adenoid hypertrophy and its association was analysed statistically. Adenoid hypertrophy (AH) in 18–25, 26–35, 36–45 and 46–55 years age group are 56.25, 28.12, 12.5, 3.125% respectively with a male:female ratio of 3:1. None of the patients were above 56 years in the study. No statistically significant association could be derived between chronic nasal and middle ear pathologies with AH. AH is a vital cause of nasal obstruction in adult population with a rising frequency these days owing to allergy, chronic infection and increased pollution. The entire of the individuals presenting with nasal obstruction, snoring and other nasal symptoms and chronic middle ear pathologies; AH should at all times be kept in mind as a ground and the patients shall be appraised for adenoid hypertrophy.